81. Congenital adrenal hyperplasia
65 clinical trials,   77 drugs   (DrugBank: 20 drugs),   11 drug target genes,   65 drug target pathways

Other name(s) = "Congenital adrenal enzyme deficiency", "Congenial adrenal cortex enzyme deficiency", "Congenital Lipoid Adrenal Hyperplasia", "3β-Hydroxysteroid Dehydrogenase Deficiency", "21-Hydroxylase deficiency", "11β-Hydroxylase deficiency", "17α-Hydroxylase deficiency", "P450 oxidoreductase deficiency", "Aldosterone synthase deficiency"  collapse"Congenital adrenal enzyme deficiency", "Congenial adrenal cortex enzyme deficiency", "Congenital Lipoid Adrenal Hyperplasia", "3β-Hydroxysteroid Dehy ... show all

Specific pediatric chronic diseases, Japan
• 5-25-50. Congenital lipoid adrenal hyperplasia
• 5-25-51. 3 beta-hydroxysteroid dehydrogenase deficiency
• 5-25-52. 11 beta-hydroxylase deficiency
• 5-25-53. 17 alpha-hydroxylase deficiency
• 5-25-54. 21-hydroxylase deficiency
• 5-25-55. P450 oxidoreductase deficiency